Astatine: A Glimpse into the Rarest Element
Astatine (At) is a chemical element with atomic number 85. It is the heaviest known halogen and is positioned below iodine in the periodic table. As a highly radioactive element, all of its isotopes are unstable and decay rapidly. This inherent instability makes astatine exceptionally rare and challenging to study.
Absence of Common, Everyday Uses
Astatine does not possess any common, everyday uses due to its extreme rarity, very short half-life, and intense radioactivity. The longest-lived isotope, Astatine-210, has a half-life of only 8.1 hours. This means that any synthesized amount quickly diminishes, making it impractical for any widespread application. Its existence is primarily of scientific interest.
While not for common use, astatine isotopes, particularly Astatine-211, are of significant interest in experimental medical research, specifically for targeted alpha therapy (TAT) in oncology. In this therapy, Astatine-211, when attached to a targeting molecule, delivers high-energy alpha particles directly to cancer cells, minimizing damage to surrounding healthy tissue. Research into such advanced cancer treatments is ongoing globally, including in various research institutions and hospitals in India that focus on nuclear medicine and oncology. However, these are highly specialized experimental procedures and not “common” or “everyday” applications.
Natural Occurrence on Earth
Astatine is the rarest naturally occurring element in Earth’s crust. It is not found in macroscopic quantities but exists transiently as an intermediate product in the natural radioactive decay chains of heavier elements such as uranium-235, uranium-238, and thorium-232.
For instance, minute, fleeting amounts of astatine are produced when uranium-235 undergoes alpha decay to protactinium-231, which then decays further, eventually leading to trace amounts of astatine. Similarly, astatine isotopes can arise from the decay series of uranium-238 and thorium-232. Given India’s significant reserves of thorium (e.g., in the monazite sands of Kerala) and uranium (e.g., in Jharkhand), the presence of their decay products, including transient astatine, is theoretically possible in these regions, albeit in extremely minute and undetectable quantities.
Extraction and Industrial Use
Due to its minuscule natural abundance and extremely short half-life, astatine is not extracted from natural sources in any practical sense. The quantities formed naturally are far too small and decay too quickly to be collected or utilized.
Astatine for research purposes is almost exclusively produced synthetically in laboratories. The primary method involves bombarding bismuth-209 with energetic alpha particles (helium nuclei) using a particle accelerator, such as a cyclotron. This nuclear reaction converts bismuth-209 into astatine-211 and neutrons.
Industrially, astatine has no widespread uses. Its application is limited to highly specialized scientific research, primarily in nuclear physics, chemistry, and experimental medicine, specifically for the development of radiopharmaceuticals for cancer therapy as mentioned previously. The synthesis and handling of astatine require specialized facilities and expertise due to its intense radioactivity and short half-life.